Global Vascular Embolotherapy Market Research Report Segmentation By Product Type (Microspheres, Embolic coils, Embolic Plug Systems, Detachable Ballons, Liquid Embolic Agents, Others); Indication (Peripheral Vascular Disease, Neurovascular Disease, Oncology, Uterine Fibroids, Varicocele, Others); End-User (Retail, Food and Beverage, Pharmaceuticals, Logistics); Region Forecast 2023 - 2030

Market Size and Overview:

The Global Vascular Embolotherapy Market was estimated to be worth USD 3.8 Billion in 2022 and is projected to reach a value of USD 7.03 Billion by 2030, growing at a CAGR of 6% during the outlook period 2023-2030.

In contrast to traditional surgical approaches, embolization represents a minimally invasive therapeutic method that obstructs one or more blood arteries or anomalous vascular pathways. This technique, utilized in interventional radiology, involves the mechanical occlusion of blood flow through a blood artery or vascular region. The application of embolization extends to various medical purposes, such as addressing malignancies, redirecting blood circulation, or mitigating vascular abnormalities. It is acknowledged for its efficacy and common utilization in the field.

Key Market Insights:

Providers of vascular embolization leverage mechanical occlusion to achieve successful outcomes, offering advantages such as a high success rate, infrequent use of general anesthetics, expedited recovery periods, low infection risks, and absence of scarring. The escalating demand for less invasive procedures is anticipated to drive substantial growth in this market, exemplified by the notable increase in angioplasties in the United States, as reported by the American College of Cardiology.

The global vascular embolotherapy market's development is propelled by several factors, including the increasing prevalence of vascular diseases, advancements in embolization products and techniques, intensified research and development initiatives, and a growing preference for less invasive methodologies. This expansion is further fueled by a surge in minimally invasive procedures and rising incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids. Additionally, the market is influenced by heightened research funding and investments from public-private collaborations.

Drivers of the Global Vascular Embolotherapy Market:

Escalating Global Incidence of Vascular Ailments Drives Growth in the Vascular Embolotherapy Market:

The global prevalence of vascular diseases is projected to rise significantly, propelling the growth of the vascular embolotherapy market. Vascular diseases, affecting the blood vessel network, include cardiovascular diseases, which, according to the World Health Organization, contribute to a substantial portion of global mortality.

Embolization Products and Strategies  Catalysts for Growth in the Vascular Embolotherapy Market:

 Anticipated advancements in embolization products and techniques are poised to further stimulate the expansion of the global vascular embolotherapy market. For instance, Terumo Medical Corporation's introduction of the AZUR Vascular Plugin signifies a milestone, being the first plug-like device with a micro-catheter designed to occlude arteries with up to 8 mm in diameter.

Challenges in the Global Vascular Embolotherapy Market:

The intricacies of vascular embolotherapy processes and equipment pose challenges in training and application for medical practitioners. Despite progress, awareness of the advantages and accessibility of vascular embolotherapy remains limited among both medical professionals and patients, potentially impeding market growth. Stringent regulatory clearances and safety evaluations for products used in vascular embolotherapy can lead to delays and increased development costs.

The shortage of skilled medical professionals, including surgeons and oncologists, is a pressing concern globally. The scarcity of specialized practitioners, especially in regions like the United States and India, is expected to impact the adoption of embolotherapy techniques. Divergent reimbursement regulations and coverage for vascular embolotherapy across different regions add complexity and financial burden for patients and healthcare professionals alike.

Global Vascular Embolotherapy Market Segmentation:

By Product Type:

• Microspheres
• Embolic coils
• Embolic Plug Systems
• Detachable Balloons
• Liquid Embolic Agents
• Others

Small, spherical particles known as microspheres are utilized in embolization procedures to restrict or halt blood flow to specific areas. Typically composed of biocompatible materials like gelatin or acrylic, these microspheres play a crucial role in achieving targeted embolization.Embolic coils, consisting of small metallic wires, are introduced into blood arteries to promote clotting and obstruct blood flow. Commonly employed in the treatment of vascular abnormalities and aneurysms, these coils contribute to the effectiveness of embolotherapy techniques.Specifically designed to physically block off blood vessels or shunts, embolic plug systems utilize plug-like devices inserted through catheters to stop blood flow. This method proves beneficial in various embolization procedures, offering a versatile approach to vascular intervention. Inflatable devices referred to as detachable balloons are deployed within blood arteries, serving to temporarily or permanently impede blood flow. Widely used in managing aneurysms and arteriovenous malformations, these balloons provide a valuable tool in the toolkit of vascular embolotherapy. Injectable compounds known as liquid embolic agents are applied to obstruct blood arteries. These substances have the capability to harden or polymerize after injection, effectively blocking blood flow and contributing to the success of embolization procedures.

By Indication:

• Peripheral Vascular Disease
• Neurovascular Disease
• Oncology
• Uterine Fibroids
• Varicocele
• Others

The treatment of diseases affecting peripheral arteries, including arteriovenous malformations (AVMs), deep vein thrombosis (DVT), and peripheral arterial disease (PAD). Vascular embolotherapy techniques are applied to occlude or cease blood flow in damaged arteries.Addressing diseases damaging blood vessels in the brain and central nervous system, such as arteriovenous malformations (AVMs), intracranial aneurysms, and other neurovascular conditions, through vascular embolotherapy. In the realm of interventional oncology, vascular embolotherapy plays a crucial role by blocking the blood supply to tumors using embolic agents. This denies tumors nutrition, leading to tumor necrosis or shrinkage and is commonly employed in treating solid tumors like liver cancer and renal cancer.Vascular embolization, also known as uterine fibroid embolization (UFE) or uterine artery embolization (UAE), provides a minimally invasive alternative to surgical fibroid excision. This technique involves restricting blood supply to fibroids, inducing contraction and relieving symptoms.Vascular embolotherapy is applied in the management of varicoceles, demonstrating its versatility in addressing a range of vascular conditions.

By End-User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Hospitals serve as the primary recipients of vascular embolotherapy treatments, equipped with the necessary facilities, trained medical personnel, and advanced equipment to execute intricate embolization procedures. Their prominence in the market is attributed to the variety of embolization treatments offered and the substantial patient volume they cater to.Both general and specialized clinics contribute to the vascular embolotherapy industry, providing outpatient treatments with specialized focuses, such as interventional radiology or vascular surgery. These clinics offer accessibility and ease of use for patients requiring embolization procedures that do not necessitate hospitalization.ASCs, or ambulatory surgery centers, cater to the demand for same-day surgical techniques like vascular embolotherapy. Known for delivering high-quality care at a lower cost, ASCs have gained popularity as a favorable option for less complex embolization treatments.

By Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

The North American region, including the United States, experiences market expansion driven by key players capitalizing on emerging opportunities, improved healthcare infrastructure, and a substantial patient population for targeted illnesses. The European market for embolotherapy benefits from the presence of key market players, efforts towards acquisitions and expansions, and a focus on securing governmental and insurance approvals. The acquisition of BTG has notably contributed to the growth of companies like Boston Scientific Corporation.The Asia Pacific region sees growing market opportunities, with key market players expanding their presence to tap into the potential offered by these nations. The improving healthcare infrastructure and a large patient population further contribute to market expansion.In the Middle East and Africa, efforts by key market players to seize emerging opportunities, coupled with advancements in healthcare infrastructure, contribute to the growth of the embolotherapy market.South America experiences market expansion, driven by the presence of key market players, strategic investments, and a growing patient population with targeted illnesses.

Impact of COVID-19 on the Global Vascular Embolotherapy Market:

The COVID-19 pandemic caused significant disruptions in healthcare systems globally, resulting in the postponement or cancellation of numerous non-emergency procedures, including vascular embolotherapy. This temporary reduction in demand highlighted the need for minimally invasive techniques, emphasizing the importance of procedures like vascular embolotherapy as alternatives to more invasive surgeries. The increased focus on minimizing hospital stays and infection risks during the pandemic is expected to influence market preferences, potentially driving the market in the long term.

Recent Developments in the Global Vascular Embolotherapy Market:

March 2022:Continued research and development focus on expanding vascular embolotherapy indications, exploring novel applications such as the treatment of liver cancer, uterine fibroids, and benign prostatic hyperplasia.

October 2023:Introduction of the HELIOSTAR™ Balloon Ablation Catheter in Europe by Biosense Webster, Inc., a Johnson & Johnson MedTech division, representing the first radiofrequency balloon ablation catheter.

September 2021:Introduction of the ICEfx Cryoablation System by BTG International, a minimally invasive tool for treating tumors and vascular issues by freezing tissue with liquid nitrogen.

Key Players in the Global Vascular Embolotherapy Market:

• Terumo Corporation
• Medtronic plc
• BTG International Ltd. (Part of Boston Scientific Corporation)
• Stryker Corporation
• Cook Medical Inc.
• Merit Medical Systems Inc.
• Johnson & Johnson (Cerenovus)
• Penumbra Inc.
• Boston Scientific Corporation
• Cardinal Health Inc.